Navigation Links
Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
Date:2/16/2012

PITTSBURGH and NEW YORK, Feb. 16, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue™, which will be manufactured and marketed by Sanofi-Aventis. According to the terms of the settlement, Intelliject and Sanofi-Aventis may launch e-cue no earlier than Nov. 15, 2012, subject to receipt of final approval from the U.S. Food and Drug Administration.

Meridian manufactures EpiPen® Auto-Injector and Mylan Specialty markets and distributes the product in the United States.

Mylan Chief Executive Officer Heather Bresch commented, "We are pleased with this settlement, and are confident that the EpiPen® Auto-Injector will continue to be a market leader, given the proud, 20-year heritage of this important treatment for anaphylaxis. Anaphylaxis poses a life-threatening risk for many, and yet there continues to be low awareness of the signs, symptoms or steps that can be taken to be prepared to respond when anaphylaxis occurs - including ensuring immediate access to epinephrine auto-injectors. That is why we believe that, in addition to our significant efforts in this area, people with life-threatening allergic reactions will benefit from more voices in the fight to raise anaphylaxis awareness, preparedness and access to treatment."

Additional terms of the agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.

About EpiPen Auto-Injector'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
2. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
3. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
4. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
5. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
6. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
7. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
8. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
9. Mylan Launches First Generic Version of Teveten® Tablets
10. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
11. Mylan Receives WHO Approval for Innovative Second-Line-in-a-Box HIV/AIDS Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 InfuSystem Holdings, ... infusion pumps and related services for the U.S. healthcare ... and full year 2014 financial results on Monday, March ... Company will also conduct a conference call for investors ... Time to discuss fourth quarter and full year 2014 ...
(Date:3/4/2015)... 4, 2015 Acsis Inc., the market leader ... announced it will be hosting a free webinar on ... "How to Boost Manufacturing Efficiency and Optimize Supply Chain ... 2:00 PM EDT.  Presenters John ... John Gordon , Chief Information Officer for Roosevelt Paper, ...
(Date:3/4/2015)... The March 3, 2015, order from the Federal Drug Administration ... labels to clarify the drugs, intended use and warn about ... to protect the public from injury from these products, according ... Hanly Conroy . The order says that the ... currently taken by millions of U.S. men – are approved ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2
(Date:3/4/2015)... growing influence of movies, television, video games and the internet ... with the increasingly frantic lifestyle of modern parents, it can ... what kids are into these days. It seems that every ... , The same is also true for drugs and alcohol. ... talk about them, are constantly changing. These tips put a ...
(Date:3/4/2015)... Blake’s All Natural Foods , ... attend this year’s Natural Products Expo West in Anaheim, ... this new line, Blake’s, who has the top four ... its commitment to creating high-quality dishes that are easily ... the natural channel, Blake’s understands what educated consumers are ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
(Date:3/4/2015)... 04, 2015 Starting February 2015, Dr. ... PRK procedures at their new location in Surrey. , ... King and Dr. Gabriel Chu also provide comprehensive ophthalmology ... is named Fraser Valley Cataract and Laser (FVCL). This ... the College of Physicians and Surgeons of British Columbia. ...
(Date:3/4/2015)... Vancouver chiropractic clinic, Backs in ... in the prestigious Vancouver Courier “Stars of Vancouver” ... The company secured third place in the “Best ... Registered Massage Therapist” category. , As one ... The Vancouver Courier is a semiweekly local newspaper ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2
... patients before flight may prevent many adverse events, researchers ... acutely ill patients who travel by emergency air transport, ... die, suffer from dangerously low blood pressure or need ... Women are at special risk, as are those with ...
... , WALTHAM, Mass., Sept. 15 Decision Resources, ... healthcare issues, finds that the uptake of novel therapies will drive the ... 2008 to more than $3.2 billion in 2018 in the United States, ... The new Pharmacor report entitled Obesity finds that ...
... , , , , ... Systems, Inc., prepares to walk the red carpet on September 15 during ... NOT the same man who blew the whistle on his employer in ... largest price-fixing schemes in corporate history and ultimately landing him in federal ...
... , , JACKSONVILLE, Fla., Sept. ... (BCBSF) announces today its plans to offer coverage for the ... becomes commercially available to the public. The vaccine administration will ... as well as for those members whose plans currently do ...
... , , CRANBURY, N.J., Sept. 15 ... that a poster on clinical trial results with PL-3994, its ... 13th Annual Scientific Meeting of the Heart Failure Society of ... Phase 2A study of PL-3994 in controlled hypertensive volunteers who ...
... , HIGH POINT, N.C., Sept. 15 Dr. ... North Carolina, has formed a company that creates mantra and ... studies have shown that mantras, prayer and meditation techniques can ... problems and ease emotional problems. In many cases, these studies ...
Cached Medicine News:Health News:Emergency Medical Transport By Air Carries Risks 2Health News:The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018 2Health News:The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018 3Health News:Former Corporate Whistleblower Says 'The Informant' Movie is Only Part of the Story 2Health News:Former Corporate Whistleblower Says 'The Informant' Movie is Only Part of the Story 3Health News:BCBSF to Cover the Administration of H1N1 Vaccination for All Members 2Health News:Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 2Health News:Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 3Health News:Medical Doctor Creates 'Mantra Medicine' Company 2Health News:Medical Doctor Creates 'Mantra Medicine' Company 3
... The DexCom STS Continuous Glucose Monitoring System ... transmits blood glucose readings to the DexCom STS ... sensor which is inserted via the DexCom STS ... the skin where it is held in place ...
... Eclipse,Plus or 850 ECG medical ... capability. Doctors,maintain all the benefits ... and gain the,ability to view ... personal computers., With diagnostic-quality viewing ...
... For practices performing routine ... with QuickStep Wizard provides a,practical, ... tightly managed health care,environment. This ... available in a variety,of configurations ...
... that need an advanced ... Vision,Premier Holter System provides ... Vision Premier system,adds expanded ... comprehensive list of diagnostic,codes ...
Medicine Products: